PCOS affects roughly one in five women and is closely tied to insulin resistance, yet it remains underdiagnosed, undertreated, and widely misunderstood. According to Kovalev, many women seeking help ...

remove-circle Internet Archive's in-browser video "theater" requires JavaScript to be enabled. It appears your browser does not have it turned on. Please see your ...

Alexion, AstraZeneca Rare Disease's Koselugo (selumetinib), an oral, selective MEK inhibitor, has been approved in Canada for the treatment of adult patients with neurofibromatosis type 1 (NF1) who ...